Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-31 @ 11:56 PM
Study NCT ID:
NCT01556594
Status:
COMPLETED
Last Update Posted:
2019-09-23
First Post:
2012-03-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03
Start Date Type:
None
Primary Completion Date:
2012-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-07
Completion Date Type:
ACTUAL
First Submit Date:
2012-03-15
First Submit QC Date:
None
Study First Post Date:
2012-03-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-03-18
Results First Submit QC Date:
None
Results First Post Date:
2014-08-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-05
Last Update Post Date:
2019-09-23
Last Update Post Date Type:
ACTUAL